Evzio, Kloxxado, Narcan, Nyxoid (naloxone) is a small molecule pharmaceutical. Naloxone was first approved as Evzio on 1982-01-01. It is used to treat opioid-related disorders, respiration disorders, and septic shock in the USA. It has been approved in Europe to treat opioid-related disorders. The pharmaceutical is active against delta-type opioid receptor and kappa-type opioid receptor. In addition, it is known to target mu-type opioid receptor. Naloxone hydrochloride's patents are valid until 2035-03-20 (FDA).
|Indication||opioid-related disorders, respiration disorders, septic shock|
|Drug Class||Narcotic agonists/antagonists (normorphine type)|